Addex Therapeutics (NASDAQ:ADXN – Get Free Report) will likely be releasing its earnings data before the market opens on ...

Stelios Papadopolous, Ph.D., a pioneering leader in biotech, appointed to Board of Directors; two industry veterans joined management team as ...

a novel orally active metabotropic glutamate receptor subtype 2 positive allosteric modulator (mGlu2 PAM) for the treatment of epilepsy; and GABAB PAM for the treatment of pain, anxiety ...

announced today that positive results from the Company’s novel gamma-aminobutyric acid sub-type B receptor (GABAB) positive allosteric modulator (PAM) chronic cough program will be presented ...

Allosteric modulators bind to their target receptor outside of the active site ... Addex is also holding on to a GABAB PAM programme for substance use disorder licensed to Indivior, follow ...

Baclofen is a GABA B receptor agonist used clinically to manage spasticity. It has also been associated with increased duration of mechanical ventilation and rates of aspiration pneumonitis. We ...

The antibodies are directed against essential membrane receptors or ion channels involved in transmission ... However, multiple antibody testing (for NMDAR, LGI1, CASPR2, AMPAR, GABA B R and GlyR) may ...

GABA supplements have gained popularity as a natural way to reduce anxiety, promote relaxation, and improve sleep quality.

Receptors on B and T cells hint at what the immune system is targeting. An AI approach called Mal-ID developed increases diagnostic accuracy, particularly for autoimmune diseases. Your immune ...